AQST earnings: next report 2026-08-10, real EPS beat/miss history, analyst consensus Buy, P/E -6.46. Updated 2026-07-23.
Aquestive Therapeutics (AQST) Research Hub
Aquestive Therapeutics (AQST) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 4.78 USD (-7.18%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -6.46, market cap 0.39B. This hub links to the full technical, earnings and options research available for AQST.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.78 USD (-7.18%) |
| 52-week range | 3.56 USD – 5.49 USD |
| Trend regime | Range |
| 14-day RSI | 63.8 (Bullish) |
| Trailing P/E | -6.46 |
| Market cap | 0.39B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for AQST
Covered Call on AQST: how it works, illustrative setup around the real 4.78 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on AQST: how it works, illustrative setup around the real 4.78 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on AQST: how it works, illustrative setup around the real 4.78 USD price, max profit/loss, breakeven and when to use it. Educational.
AQST technical analysis: range, last 4.78 USD, RSI 63.8, 52w range 3.56 USD–5.49 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is AQST in?
Aquestive Therapeutics (AQST) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, US.
Is AQST in an uptrend or downtrend?
As of 2026-09-11, AQST is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is AQST's trailing P/E ratio?
AQST's trailing P/E is -6.46, with a market cap of 0.39B. See the earnings research page for full valuation detail.
When does AQST next report earnings?
AQST is next scheduled to report earnings on 2026-08-10, with a consensus EPS estimate of -0.1 USD.